Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 04 Jul 2023

Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist

in Cancer Immunity and Immunotherapy

Yukang Lu
Mengting Zhang
Jiajun Zhou
Xiulan Liu
Lanfeng Wang
Xinyi Hu
Yiping Mao
Rongfa Gan
Zhiping Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212101

4,038 views
3 citations

Case Report

Published on 04 Jul 2023

Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx

in Cancer Immunity and Immunotherapy

Bao Sun
Zhiying Luo
Ping Liu
Yan He
Shasha He
Wenhui Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1190210

2,303 views
2 citations

Review

Published on 03 Jul 2023

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy

in Cancer Immunity and Immunotherapy

Areez Shafqat
Mohamed H. Omer
Eman Nayaz Ahmed
Ali Mushtaq
Eman Ijaz
Zara Ahmed
Khaled Alkattan
Ahmed Yaqinuddin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1200941

5,560 views
15 citations

Original Research

Published on 03 Jul 2023

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma

in Cancer Immunity and Immunotherapy

Xiaoyu Mao
Fanglong Song
Ju Jin
Bin Zou
Peijun Dai
Mingjuan Sun
Weicheng Xu
Lianghua Wang
Yifan Kang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1202725

5,346 views
10 citations

Editorial

Published on 03 Jul 2023

Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II

in Cancer Immunity and Immunotherapy

Yueyi Li
Yusha Wang
Jinsheng Gao
Keqin Tan
Benjamin Frey
Udo S. Gaipl
Hubing Shi
Xuelei Ma

Frontiers in Immunology

doi 10.3389/fimmu.2023.1222675

1,981 views

Original Research

Published on 03 Jul 2023

Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models

in Cancer Immunity and Immunotherapy

Efthymia Papaevangelou
Ana M. Esteves
Prokar Dasgupta
Christine Galustian

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196829

4,224 views
8 citations

Review

Published on 03 Jul 2023

MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target

in Cancer Immunity and Immunotherapy

Haoyu Liu
Zhicheng Wang
Yuntao Zhou
Yanming Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199273

7,999 views
26 citations

Review

Published on 03 Jul 2023

Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer

in Cancer Immunity and Immunotherapy

Luyao Wang
Zongxing Yang
Fucheng Guo
Yurong Chen
Jiarui Wei
Xiangpeng Dai
Xiaoling Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1227797

6,145 views
10 citations

General Commentary

Published on 30 Jun 2023

Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma

in Cancer Immunity and Immunotherapy

Ruihuan Shen
Tong Zou

Frontiers in Immunology

doi 10.3389/fimmu.2023.913339

1,034 views

Original Research

Published on 30 Jun 2023

The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer

in Cancer Immunity and Immunotherapy

Qian Song
Song-Xiao Xu
Jun-Zhou Wu
Lin Ling
Sheng Wang
Xin-Hua Shu
Dan-Ni Ying
Wang-Wei Pei
Yu-Chen Wu
Su-Fang Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1177403

4,332 views
16 citations

Original Research

Published on 30 Jun 2023

PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer

in Cancer Immunity and Immunotherapy

Behnia Akbari
Tahereh Soltantoyeh
Zahra Shahosseini
Farhad Jadidi-Niaragh
Jamshid Hadjati
Christine E. Brown
Hamid Reza Mirzaei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1209572

6,993 views
13 citations

Original Research

Published on 30 Jun 2023

Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Hanyao Guo
Sidi Zhang
Bo Zhang
Yanan Shang
Xiaoyu Liu
Meixia Wang
Hongyu Wang
Yumei Fan
Ke Tan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1202324

5,180 views
2 citations

Review

Published on 30 Jun 2023

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems

in Cancer Immunity and Immunotherapy

Ya-long Yang
Fei Yang
Zhuan-qing Huang
Yuan-yuan Li
Hao-yuan Shi
Qi Sun
Yue Ma
Yao Wang
Ying Zhang
Sen Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199173

9,809 views
44 citations

Original Research

Published on 29 Jun 2023

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma

in Cancer Immunity and Immunotherapy

Boyu Pan
Xiaoyun Cheng
Wei Tan
Renfeng Liu
Xin Wu
Jinpeng He
Qizhi Fan
Yan Zhang
Jun Cheng
Youwen Deng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188256

4,514 views
6 citations

Original Research

Published on 29 Jun 2023

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Huarong Zhou
Bei Jia
Charyguly Annageldiyev
Kentaro Minagawa
Chenchen Zhao
Shin Mineishi
W Christopher Ehmann
Seema G. Naik
Joseph Cioccio
Baldeep Wirk

Frontiers in Immunology

doi 10.3389/fimmu.2023.1169144

3,789 views
5 citations

Original Research

Published on 29 Jun 2023

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning

in Cancer Immunity and Immunotherapy

Li Gong
Jun Gong
Xin Sun
Lin Yu
Bin Liao
Xia Chen
Yong-sheng Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1138489

4,286 views
10 citations